Paolo Costigliola
- Virology top 5%
- HIV Research and Treatment 13
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions 9
- HIV/AIDS drug development and treatment 9
- Epidemiology top 10%
- Pneumocystis jirovecii pneumonia detection and treatment 5
- HIV, Drug Use, Sexual Risk 4
- Microbiology top 10%
- General Health Professions top 10%
-
- Hepatitis C virus research 5
-
- HIV-related health complications and treatments 5
-
- Viral-associated cancers and disorders 4
In The Last Decade
Paolo Costigliola
32 papers receiving 547 citations
Peers
Comparison fields: 5 of 78
- Virology 156
- Infectious Diseases 332
- Epidemiology 255
- Microbiology 41
- General Health Professions 125
Countries citing papers authored by Paolo Costigliola
This map shows the geographic impact of Paolo Costigliola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Costigliola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Costigliola more than expected).
Fields of papers citing papers by Paolo Costigliola
This network shows the impact of papers produced by Paolo Costigliola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Costigliola. The network helps show where Paolo Costigliola may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paolo Costigliola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 35 | |
| 2 | 2006 | 15 | |
| 3 | 2004 | 1 | |
| 4 | Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters. | 2000 | 4 |
| 5 | 1999 | 6 | |
| 6 | 1998 | 6 | |
| 7 | 1995 | 28 | |
| 8 | 1993 | 15 | |
| 9 | 1993 | 14 | |
| 10 | 1992 | 2 | |
| 11 | 1992 | 12 | |
| 12 | 1992 | 15 | |
| 13 | 1992 | 16 | |
| 14 | 1992 | 14 | |
| 15 | [Monitoring of several hematological parameters of the erythroid series in patients with HIV infection treated with zidovudine]. | 1992 | 2 |
| 16 | 1991 | 24 | |
| 17 | 1990 | 16 | |
| 18 | 1989 | 7 | |
| 19 | 1987 | 11 | |
| 20 | Vertical transmission of HTLV-III [letter] | 1986 | 5 |
About Paolo Costigliola
Paolo Costigliola is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 34 papers that have together received 573 indexed citations. Recurring topics across this work include HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (9 papers), HIV/AIDS drug development and treatment (9 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Hepatitis C virus research (5 papers), HIV-related health complications and treatments (5 papers), Viral-associated cancers and disorders (4 papers) and HIV, Drug Use, Sexual Risk (4 papers). The work is most often cited by research in Virology (156 citations), Infectious Diseases (332 citations) and Epidemiology (255 citations). Paolo Costigliola has collaborated with scholars based in Italy, Bulgaria and China. Frequent co-authors include Massimo Musicco, Claudio Arici, Francesco Chiodo, Adriano Lazzarin, Roberto Luzzati, Gioacchino Angarano, S. Gafà, Roberto Manfredi, A. Saracco and Giovanna Gavazzeni. Their work appears in journals such as The Lancet, Blood and International Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.